Tridihexethyl chloride

Base Information

• Chemical Name: Tridihexethyl chloride
• CAS No.: 4310-35-4
• Molecular Formula: C21H36 N O . Cl
• Molecular Weight: 353.976
• Hs Code.: 2923900090
• European Community (EC) Number: 224-323-3
• UNII: 25YK75CYMX
• DSSTox Substance ID: DTXSID4023701
• Wikidata: Q27108476
• NCI Thesaurus Code: C66632
• Metabolomics Workbench ID: 53494
• ChEMBL ID: CHEMBL1200771
• Mol file: 4310-35-4.mol

Synonyms:(3-cyclohexyl-3-hydroxy-3-phenylpropyl)triethylammonium iodide;chloride of tridihexethyl;Pathilon;tridihexethyl;tridihexethyl decylsulfate;tridihexethyl iodide;tridihexylethyl chloride

Chemical Property of Tridihexethyl chloride

Chemical Property:

• Boiling Point: °Cat760mmHg
• Flash Point: °C
• PSA: 20.23000
• Density: g/cm³
• LogP: 1.72510
• Hydrogen Bond Donor Count: 1
• Hydrogen Bond Acceptor Count: 2
• Rotatable Bond Count: 8
• Exact Mass: 353.2485425
• Heavy Atom Count: 24
• Complexity: 319

Purity/Quality:

99% ^*data from raw suppliers

TridihexethylChloride ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: CC[N+](CC)(CC)CCC(C1CCCCC1)(C2=CC=CC=C2)O.[Cl-]
• Uses: Tridihexethyl Chloride, is an anticholinergic, antimuscarinic and antispasmodic drug.
• Clinical Use: tridihexethyl chloride is useful for adjunctive therapy in a wide varietyof GI diseases, such as peptic ulcer, gastric hyperacidity,and hypermotility and spastic conditions, such as spasticcolon, functional diarrhea, pylorospasm, and other relatedconditions. Because its action is predominantly antisecretory,it is more effective in gastric hypersecretion than in hypermotilityand spasm. It is best administered intravenouslyfor the latter conditions. The side effects usually found with effective anticholinergictherapy occur with the use of this drug. These are drynessof mouth, mydriasis, and such. As with other anticholinergics,care should be exercised when administering the drug topatients with glaucomatous conditions, cardiac decompensation,and coronary insufficiency. It is contraindicated inpatients with obstruction at the bladder neck, prostatic hypertrophy,stenosing gastric and duodenal ulcers, or pyloric orduodenal obstruction.